FDA Inspection
Bausch & Lomb IncorporatedBausch & Lomb Incorporated – FDA Inspection, Jul 12, 2013
Record Details
This FDA Inspection record concerns Bausch & Lomb Incorporated, with an inspection on July 12, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bausch & Lomb Incorporated
- Inspection Date
- July 12, 2013
- Product Type
- Drugs
View Company Profile
ID · f3732418-84d2-4954-9bb8-7f8ed4258c2f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 840876
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bausch & Lomb Incorporated
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Florida District Office | |
| August 25, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2017 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
Other documents for Bausch & Lomb Incorporated
- FDA Inspection 1304548 - 2026-03-20
- FDA Inspection 1218198 - 2023-08-25
- FDA Inspection 1082137 - 2019-01-30
- FDA Inspection 1061913 - 2018-08-10
- FDA Inspection 1015001 - 2017-05-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.